Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication February 1, 2019
- Accepted for publication May 29, 2019
- Published online December 2, 2019.
Article Versions
- previous version (August 12, 2019 - 06:13).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Zohreh Varasteh1,
- Sarajo Mohanta2,3,
- Stephanie Robu1,
- Miriam Braeuer1,
- Yuanfang Li2,
- Negar Omidvari1,
- Geoffrey Topping1,
- Ting Sun2,
- Stephan G. Nekolla1,
- Antonia Richter1,
- Christian Weber2,3,
- Andreas Habenicht2,
- Uwe A. Haberkorn4 and
- Wolfgang A. Weber1
- 1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
- 2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
- 3German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and
- 4Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
- For correspondence or reprints contact: Zohreh Varasteh, Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Ismaningerstrasse 22, 81675 Munich, Germany. E-mail: zohreh.varasteh{at}tum.de
Cited By...
Article usage
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04
Jump to section
Related Articles
Cited By...
- Targeted PET Imaging of Chemokine Receptor 2-Positive Monocytes and Macrophages in the Injured Heart
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year
- The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
- CARTing Away Cardiac Fibrosis
- FAP: The Next Billion Dollar Nuclear Theranostics Target?